BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10567241)

  • 1. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells.
    Baulida J; Batlle E; García De Herreros A
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):565-70. PubMed ID: 10567241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
    Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
    Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjö A; Söderkvist P
    Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
    Park CH; Hahm ER; Park S; Kim HK; Yang CH
    FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
    Omer CA; Miller PJ; Diehl RE; Kral AM
    Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.
    Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ
    Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.